Aurora cannabis message board
[PDF File] AURORA CANNABIS INC.
http://5y1.org/file/13796/aurora-cannabis-inc.pdf
AURORA CANNABIS INC. Condensed Consolidated Interim Financial Statements (Unaudited) For the three and six months ended December 31, 2020 and 2019 (in Canadian Dollars) Table of Contents Condensed Consolidated Interim Statements of Financial Position..... 3 Condensed Consolidated Interim Statements of Comprehensive …
[PDF File] ONTARIO CANNABIS STORE ANNUAL REPORT
http://5y1.org/file/13796/ontario-cannabis-store-annual-report.pdf
As Chair of the Ontario Cannabis Retail Corporation (OCRC) Board of Directors, I am pleased to present the agency’s Annual Report. The report covers the fiscal period from April 1, 2022, to March 31, 2023. Sincerely, Connie Dejak Chair – Board of Directors Ontario Cannabis Retail Corporation. OCRC ANNUAL REPORT 2022–2023 03 TABLE …
[PDF File] Annual report: AURORA CANNABIS INC - Erste Group
http://5y1.org/file/13796/annual-report-aurora-cannabis-inc-erste-group.pdf
Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through the Canadian Adult- Use and International Medical Cannabis segments. The company was founded by Terry Booth and Steve Dobler on December 21, 2006 and is …
[PDF File] AURORA CANNABIS INC.
http://5y1.org/file/13796/aurora-cannabis-inc.pdf
During the three months ended September 30, 2023, medical cannabis net revenue was $43.8 million as compared to the three months ended June 30, 2023 of $41.6 million, and $31.0 million during the three months ended September 30, 2022, representing an increase of $2.2 million and $12.9 million, respectively.
[PDF File] AURORA CANNABIS INC.
http://5y1.org/file/13796/aurora-cannabis-inc.pdf
Liquidity Update. At March 31, 2022 the Company reported $480.6 million (Q2 2022 - $383.8 million, Q3 2021 - $520.2 million) of cash and cash equivalents, including $50.7 million (Q2 2022 - $51.3 million, Q3 2021 - $50.0 million) of restricted cash. During Q3 2022, the Company utilized cash in the following categories:
[PDF File] Board Mandate (2023) (final) (00237385)
http://5y1.org/file/13796/board-mandate-2023-final-00237385.pdf
BOARD MANDATE 1. PURPOSE AND AUTHORITY . The Board of Directors (the “ Board ”) has oversight responsibilit. y. for the stewardship of Aurora Cannabis Inc. (the “ Compan. y”) and its business and is accountable to the shareholders for the performance of the Company. The Board has clearly delineated its role and the role of management. The …
[PDF File] AURORA CANNABIS INC.
http://5y1.org/file/13796/aurora-cannabis-inc.pdf
The Company’s registered and records office address is Suite 1500 – 1055 West Georgia Street, Vancouver, BC, Canada, V6E 4N7. The Company’s principal strategic business lines are focused on the production, distribution and sale of cannabis and cannabis related products in Canada and internationally.
[PDF File] AURORA CANNABIS INC.
http://5y1.org/file/13796/aurora-cannabis-inc.pdf
8. Note 1 Nature of Operations Aurora Cannabis Inc. (the “Company” or “Aurora”) was incorporated under the Business Corporations Act (British Columbia) on December 21, 2006 as Milk Capital Corp. Effective October 2, 2014, the Company changed its name to Aurora Cannabis Inc. The Company’s shares are listed on the Nasdaq …
[PDF File] AURORA CANNABIS INC.
http://5y1.org/file/13796/aurora-cannabis-inc.pdf
To the Shareholders and Board of Directors Aurora Cannabis Inc.: Opinion on the Consolidated Financial Statements We have audited the accompanying consolidated statements of financial position of Aurora Cannabis Inc. (the Company) as of June 30, 2022 and 2021, the related consolidated statements of comprehensive loss, changes in …
[PDF File] AURORA CANNABIS INC.
http://5y1.org/file/13796/aurora-cannabis-inc.pdf
As at the date of this report, the fair value of shares held in marketable securities and investments in associates was $93.3 million and the intrinsic value of derivative investments was $17.8 million. As at December 31, 2019, total capitalization decreased by $608.9 million as compared to June 30, 2019.
[PDF File] AURORA CANNABIS INC.
http://5y1.org/file/13796/aurora-cannabis-inc.pdf
To the Shareholders and Board of Directors Aurora Cannabis Inc.: Opinion on the Consolidated Financial Statements. We have audited the accompanying consolidated statements of financial position of Aurora Cannabis Inc. (the Company) as of March 31, 2023 and June 30, 2022, the related consolidated statements of loss and …
[PDF File] Aurora Cannabis Inc.
http://5y1.org/file/13796/aurora-cannabis-inc.pdf
Aurora Cannabis Inc. (Aurora) is a global leader in the cannabis industry serving both the medical and consumer markets. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis dedicated to helping people improve their lives. Health Canada requires that cannabis companies produce reports of a Security Cleared Individual’s (SCI) …
[PDF File] Ontario - Financial and Consumer Affairs Authority of Saskatchewan
http://5y1.org/file/13796/ontario-financial-and-consumer-affairs-authority-of-saskatchewan.pdf
citation: aurora cannabis inc. (re), 2018 onsec 10 date: 2018 -03-15 file nos. 2017-71, 2017-73 and 2017-74 simultaneous hearings of the financial and consumer affairs authority of saskatchewan (fcaas) and the ontario securities commission (osc) in the matter of aurora cannabis inc. – and – in the matter of cannimed therapeutics inc. – and – in the matter …
[PDF File] AURORA CANNABIS INC.
http://5y1.org/file/13796/aurora-cannabis-inc.pdf
UK, Poland, and Australia. Aurora has established a leading market position in most of these countries; and • Global consumer use cannabis market: Currently, only Canada and Uruguay have implemented federally-regulated consumer use of cannabis regimes and the Company has primarily focused on the opportunities in Canada. Longer …
[PDF File] Ontario - Financial and Consumer Affairs Authority of Saskatchewan
http://5y1.org/file/13796/ontario-financial-and-consumer-affairs-authority-of-saskatchewan.pdf
citation: aurora cannabis inc. (re), 2018 onsec 10 date: 2018 -03-15 file nos. 2017-71, 2017-73 and 2017-74 simultaneous hearings of the financial and consumer affairs authority of saskatchewan (fcaas) and the ontario securities commission (osc) in the matter of aurora cannabis inc. – and – in the matter of cannimed therapeutics inc. – and – in the matter …
[PDF File] Consolidated Financial Statements For the years ended June 30, …
http://5y1.org/file/13796/consolidated-financial-statements-for-the-years-ended-june-30.pdf
To the Shareholders and Board of Directors Aurora Cannabis Inc.: Opinion on the Consolidated Financial Statements We have audited the accompanying consolidated statements of financial position of Aurora Cannabis Inc. (the Company) as of June 30, 2020 and 2019, the related consolidated statements of comprehensive loss, changes in …
[PDF File] AURORA CANNABIS INC.
http://5y1.org/file/13796/aurora-cannabis-inc.pdf
Lease obligation payments of $1.6 million. Accordingly, as at September 30, 2021, the Company had $424.3 million of cash, comprised of $372.8 million of cash and cash equivalents and $51.5 million in restricted cash, and …
[PDF File] Reasons for Decision: In the Matter of Aurora Cannabis Inc, …
http://5y1.org/file/13796/reasons-for-decision-in-the-matter-of-aurora-cannabis-inc.pdf
citation: aurora cannabis inc. (re), 2018 onsec 10 date: 2018 -03-15 file nos. 2017-71, 2017-73 and 2017-74 simultaneous hearings of the financial and consumer affairs authority of saskatchewan (fcaas) and the ontario securities commission (osc) in the matter of aurora cannabis inc. – and – in the matter of cannimed therapeutics inc.
[PDF File] UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY
http://5y1.org/file/13796/united-states-district-court-district-of-new-jersey.pdf
John Michael Vazquez, U.S.D.J. This putative class action concerns allegations of securities fraud by purchasers of Aurora. Cannabis, Inc.’s stock between October 23, 2018 and February 6, 2020 (the “Class Period”). Plaintiffs allege that Aurora and six of its key officers engaged in securities fraud in violation of.
[PDF File] Aurora IR presentation draft v1
http://5y1.org/file/13796/aurora-ir-presentation-draft-v1.pdf
Expect to achieve a positive Adjusted EBITDA run rate by Fiscal H1 FY23. Targeting a total of $150 to $170 million of annualized savings by Fiscal H1 FY23. #1 Canadian LP in global medical cannabis revenues. Growing international medical segment, revenue was up 55% in FY22Q3 compared to last year.
[PDF File] AURORA CANNABIS INC.
http://5y1.org/file/13796/aurora-cannabis-inc.pdf
The following Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) of Aurora Cannabis Inc. (“Aurora” or the “Company”) should be read in conjunction with both the Company’s audited consolidated financial statements as at and for the year ended June 30, 2022 and the accompanying notes …
[PDF File] AURORA CANNABIS INC.
http://5y1.org/file/13796/aurora-cannabis-inc.pdf
Aurora’s International medical cannabis net revenue was $16.2 million during the three months ended June 30, 2023, as compared to $13.8 million during the three months ended March 31, 2023. The increase of $2.4 million was mainly seen in our European markets which benefited from the introduction of new cultivars.
[PDF File] Notice of Annual General Meeting of Shareholders and …
http://5y1.org/file/13796/notice-of-annual-general-meeting-of-shareholders-and.pdf
A MESSAGE FROM OUR CHIEF EXECUTIVE OFFICER June 30, 2023 Dear shareholders, We are pleased to invite you to the 2023 Annual General Meeting of Shareholders (the “Meeting”) of Aurora Cannabis Inc. (“Aurora” or the “Company”) to be held on Monday, August 14, 2023 at 1:00 pm Eastern Time.We are holding the Meeting
[PDF File] AURORA CANNABIS INC. - New Cannabis Ventures
http://5y1.org/file/13796/aurora-cannabis-inc-new-cannabis-ventures.pdf
AURORA CANNABIS INC. Condensed Interim Consolidated Statements of Cash Flows (Unaudited) Nine months ended March 31, 2016 and 2015 (In Canadian Dollars) 2016 2015
[PDF File] AURORA CANNABIS INC.
http://5y1.org/file/13796/aurora-cannabis-inc.pdf
This expense is included in the share-based compensation line on the statement of comprehensive loss. The weighted average fair value of RSUs and DSUs granted in the three and nine months March 31, 2021 was $16.36 and $11.15 per unit, respectively (three and nine months March 31, 2020 – $25.44 and $8.40 per unit).
Nearby & related entries:
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Hot searches
- corporate job description template
- is interest on life insurance taxable
- business strategy examples pdf
- tan x square root
- apa in text website cite
- assistive technology tools for students
- how tall is 5
- ministry of education fiji past exam papers
- nys physical form for school
- western province term test answers sheet